Abbott

Sales increase 14% for pharmaceutical company

Published in Pharma Investments, Ventures and Law Weekly, June 12th, 2005

At the annual meeting of Abbott shareholders, chairman and CEO Miles D. White highlighted the company's strong performance across both its Pharmaceutical Products Group and Medical Products Group in 2004, a direct result of executing on the strategy to reshape the company, giving Abbott a refined focus on high-growth, innovation-driven businesses.

"Abbott's performance was outstanding in 2004," said White. "Overall sales increased 14%, and both of our operating groups delivered double-digit growth. Our medical products business had its best performance in a decade. And our U.S. pharmaceutical business was the second-fastest growing among our peers for the second...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2005-06-12)

More Articles from Pharma Investments, Ventures and Law Weekly

A.P. Pharma, Inc.
Pharmaceutical firm reports loss of $0.05 per share, clinical trial update
AC Immune
Swiss biotech company raises CHF 21M in private financing
Acadia Pharmaceuticals, Inc.
Biopharmaceutical company reports first quarter loss of $5.6M
Access Pharmaceuticals, Inc.
Pharmaceutical firm records loss of $0.16 per share
Advancis Pharmaceutical Corporation
Private placement of common equity closed by pharma firm
Aeolus Pharmaceuticals, Inc.
Pharmaceutical company records loss of $0.12 per share, reports on ALS drug
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry